Follow
Daniel J. Drucker
Daniel J. Drucker
Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto
Verified email at lunenfeld.ca - Homepage
Title
Cited by
Cited by
Year
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
DJ Drucker, MA Nauck
The Lancet 368 (9548), 1696-1705, 2006
46052006
Biology of incretins: GLP-1 and GIP
LL Baggio, DJ Drucker
Gastroenterology 132 (6), 2131-2157, 2007
42642007
The biology of incretin hormones
DJ Drucker
Cell metabolism 3 (3), 153-165, 2006
26962006
Normalization of obesity-associated insulin resistance through immunotherapy
S Winer, Y Chan, G Paltser, D Truong, H Tsui, J Bahrami, R Dorfman, ...
Nature medicine 15 (8), 921-929, 2009
15802009
Pharmacology, physiology, and mechanisms of incretin hormone action
JE Campbell, DJ Drucker
Cell metabolism 17 (6), 819-837, 2013
14432013
FTO Obesity Variant Circuitry and Adipocyte Browning in Humans
M Claussnitzer, SN Dankel, KH Kim, G Quon, W Meuleman, C Haugen, ...
New England Journal of Medicine 373 (10), 895-907, 2015
13932015
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
DJ Drucker, JB Buse, K Taylor, DM Kendall, M Trautmann, D Zhuang, ...
The Lancet 372 (9645), 1240-1250, 2008
12352008
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor–dependent and–independent pathways
K Ban, MH Noyan-Ashraf, J Hoefer, SS Bolz, DJ Drucker, M Husain
Circulation 117 (18), 2340-2350, 2008
12052008
Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.
DJ Drucker, J Philippe, S Mojsov, WL Chick, JF Habener
Proceedings of the National Academy of Sciences 84 (10), 3434-3438, 1987
11281987
Mechanisms of action and therapeutic application of glucagon-like peptide-1
DJ Drucker
Cell metabolism 27 (4), 740-756, 2018
10862018
Glucagon-like peptide 1 (GLP-1)
TD Müller, B Finan, SR Bloom, D D'Alessio, DJ Drucker, PR Flatt, ...
Molecular metabolism 30, 72-130, 2019
10322019
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
DJ Drucker, P Erlich, SL Asa, PL Brubaker
Proceedings of the National Academy of Sciences 93 (15), 7911-7916, 1996
10101996
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
H Ellingsgaard, I Hauselmann, B Schuler, AM Habib, LL Baggio, DT Meier, ...
Nature medicine 17 (11), 1481-1489, 2011
9772011
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During, L Cao, DS Zuzga, JS Francis, HL Fitzsimons, X Jiao, RJ Bland, ...
Nature medicine 9 (9), 1173-1179, 2003
9422003
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene
LA Scrocchi, TJ Brown, N MaClusky, PL Brubaker, AB Auerbach, ...
Nature medicine 2 (11), 1254-1258, 1996
9371996
Predicting cardiac complications in patients undergoing non-cardiac surgery
AS Detsky, HB Abrams, JR McLaughlin, DJ Drucker, Z Sasson, ...
Journal of general internal medicine 1 (4), 211-219, 1986
9121986
Enhancing incretin action for the treatment of type 2 diabetes
DJ Drucker
Diabetes care 26 (10), 2929-2940, 2003
8852003
Glucagon-like peptide-1 receptor signaling modulates β cell apoptosis
Y Li, T Hansotia, B Yusta, F Ris, PA Halban, DJ Drucker
Journal of Biological Chemistry 278 (1), 471-478, 2003
8442003
Incretin-based therapies for type 2 diabetes mellitus
JA Lovshin, DJ Drucker
Nature Reviews Endocrinology 5 (5), 262-269, 2009
8312009
The role of gut hormones in glucose homeostasis
DJ Drucker
The Journal of clinical investigation 117 (1), 24-32, 2007
8172007
The system can't perform the operation now. Try again later.
Articles 1–20